The Aggregation Conditions Define Whether EGCG is an Inhibitor or Enhancer of α-Synuclein Amyloid Fibril Formation

por Sternke-Hoffmann, Rebecca, Peduzzo, Alessia, Bolakhrif, Najoua, Haas, Rainer, Buell, Alexander K.
Publicado 2020

Met/Val129 polymorphism of the full-length human prion protein dictates distinct pathways of amyloid formation

por Pauly, Thomas, Bolakhrif, Najoua, Kaiser, Jesko, Nagel-Steger, Luitgard, Gremer, Lothar, Gohlke, Holger, Willbold, Dieter
Publicado 2022